Latest filing published 31 May 2023 for Chinook Therapeutics, INC..
Ross Haghighat appears in our data through filings on Chinook Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 20 April 2015 to 26 May 2023, the count stands at 21 filings.
No open-market purchase appears, only 1 sale worth €101k. Outside the open market, there are 1 share grant and 6 option exercises.
Most recently, on 31 May 2023, the filings show an option exercise in Chinook Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations